Perspectivas Atuais sobre Terapias para a Doença de Alzheimer: Uma Análise da Literatura Contemporânea
PDF (Português (Brasil))

Keywords

Alzheimer
Tratamento
Neurologia
estratégias terapêuticas

How to Cite

Pereira Levada, L., Campos de Paiva, G., de Melo Rocha, L., Lucas Carneiro Ramos, P., Carlos Luzio Filho, A., Caroline Bennes Martelet Simões, J., Tino Barbosa Ferreira, I., Priscila Bezerra de Souza, A., Santos Arruda, L., Felipe Martins Luzio, L., Roberto Fuzari Silva, J., Sobral Dias , J., Filipe Modesto Ribeiro Cruz, A., Rafaela Gomes Taneda, B., & Siqueira leão, V. (2024). Perspectivas Atuais sobre Terapias para a Doença de Alzheimer: Uma Análise da Literatura Contemporânea. Brazilian Journal of Implantology and Health Sciences, 6(3), 312–322. https://doi.org/10.36557/2674-8169.2024v6n3p312-322

Abstract

The article provides a comprehensive review of current and emerging therapeutic strategies for the treatment of Alzheimer's disease (AD), an increasingly prevalent neurodegenerative condition in the elderly. The multifaceted complexity of treatment is highlighted, encompassing both pharmacological and non-pharmacological approaches. Acetylcholinesterase inhibitors are commonly used to improve cholinergic neurotransmission, while immunotherapy, including vaccines against beta-amyloid, is in clinical trial phase. Additionally, potential treatments such as antidiabetic agents, serotonergic psychedelics, and gene therapy are discussed. Inflammation is recognized as a crucial component in the pathogenesis of AD, and anti-inflammatory agents show promise in reducing neuroinflammation. However, challenges persist, such as validating results in humans, the lack of reliable biomarkers for early diagnosis, and the need to find effective therapeutic targets that can modify the disease's progression.

https://doi.org/10.36557/2674-8169.2024v6n3p312-322
PDF (Português (Brasil))

References

BARACALDO-SANTAMARÍA, D. et al. Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, v. 24, n. 10, p. 9067–9067, 22 maio 2023.

BHOLE, R. P.; CHIKHALE, R. V.; RATHI, K. M. Current Biomarkers and Treatment Strategies in Alzheimer Disease: An Overview and Future Perspectives. IBRO neuroscience reports, v. 16, p. 8–42, 1 jun. 2024.

BRASIL. Lei Nº 12.853. Brasília: 14 de agosto de 2013.

CUMMINGS, J. et al. Alzheimer’s disease drug development pipeline: 2023. Alzheimer’s Association, v. 9, n. 2, 1 abr. 2023.

DEVI, G. A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer’s disease. ProQuest, 17 ago. 2023.

FITZGERALD, G. S.; CHUCHTA, T. G.; MCNAY, E. C. Insulin‐like growth factor‐2 is a promising candidate for the treatment and prevention of Alzheimer’s disease. v. 29, n. 6, p. 1449–1469, 27 mar. 2023.

GUO, X. A state-of-the-art review on miRNA in prevention and treatment of Alzheimer’s disease. Journal of Zhejiang University (Medical Sciences), v. 52, n. 4, p. 485–498, 1 ago. 2023.

NOWELL, J. et al. Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease. Ageing Research Reviews, v. 89, p. 101979, 1 ago. 2023.

PENKE, B.; MÁRIA SZÜCS; FERENC BOGÁR. New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, v. 24, n. 6, p. 5383–5383, 11 mar. 2023.

R. MONTEIRO ANA et al. Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. v. 211, p. 115522–115522, 1 mar. 2023.

RAJSHRI DAFRE; PRAFUL WASNIK. Current Diagnostic and Treatment Methods of Alzheimer’s Disease: A Narrative Review. Cureus, 20 set. 2023.

TWAROWSKI, B.; HERBET, M. Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review. International Journal of Molecular Sciences, v. 24, n. 7, p. 6518, 30 mar. 2023.

WINKELMAN, M. J.; SZABO, A.; FRECSKA, E. The potential of psychedelics for the treatment of Alzheimer’s disease and related dementias. European Neuropsychopharmacology, v. 76, p. 3–16, 1 nov. 2023.

WU, W. et al. The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. European Journal of Medical Research, v. 28, n. 1, 28 nov. 2023.

ZHANG, Y. et al. Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future. Signal Transduction and Targeted Therapy, v. 8, n. 1, p. 1–26, 30 jun. 2023.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Leonardo Pereira Levada, Gabriela Campos de Paiva, Laura de Melo Rocha, Pedro Lucas Carneiro Ramos, Antonio Carlos Luzio Filho, Jeniffer Caroline Bennes Martelet Simões, Isabella Tino Barbosa Ferreira, Alexia Priscila Bezerra de Souza, Luma Santos Arruda, Luis Felipe Martins Luzio, João Roberto Fuzari Silva, Jennifer Sobral Dias , André Filipe Modesto Ribeiro Cruz, Bruna Rafaela Gomes Taneda, Victoria Siqueira leão

Downloads

Download data is not yet available.